Reuters US Business

Former First Republic workers sue FDIC over withheld retirement pay

By Douglas Gillison (Reuters) – Nearly 170 former employees of California’s failed First Republic Bank have sued the U.S. Federal Deposit Insurance Corporation (FDIC), alleging that the regulator is improperly holding up at least $150 million in retirement funds, a plaintiffs’ attorney said on Monday. The lawsuit marks the latest fallout for the FDIC from …

Former First Republic workers sue FDIC over withheld retirement pay Read More »

Adobe shelves $20 billion Figma deal after hitting regulatory roadblocks

By Akash Sriram, Chavi Mehta and Krystal Hu (Reuters) -Adobe on Monday shelved its $20 billion deal for cloud-based designer platform Figma, pointing to “no clear path” for antitrust approvals in Europe and the UK for what would have been among the biggest buyouts of a software startup. The cash-and-stock deal, announced in September last …

Adobe shelves $20 billion Figma deal after hitting regulatory roadblocks Read More »

Monsanto hit with $857M verdict over PCBs in Washington state school

By Clark Mindock (Reuters) – A jury in Washington state on Monday ordered Bayer’s Monsanto to pay $857 million to former students and parent volunteers of a school northeast of Seattle who claimed chemicals made by the company called polychlorinated biphenyls, or PCBs, leaked from light fixtures and got them sick, according to an attorney …

Monsanto hit with $857M verdict over PCBs in Washington state school Read More »

OpenAI outlines AI safety plan, allowing board to reverse decisions

By Anna Tong Artificial intelligence company OpenAI laid out a framework to address safety in its most advanced models, including allowing the board to reverse safety decisions, according to a plan published on its website Monday. Microsoft-backed OpenAI will only deploy its latest technology if it is deemed safe in specific areas such as cybersecurity …

OpenAI outlines AI safety plan, allowing board to reverse decisions Read More »

Factbox-What to expect in 2024: Fed pivot, cooling inflation, easing growth

(Reuters) -Global growth will likely slow in 2024 but a dovish tilt in the Federal Reserve’s rhetoric has raised hopes for the U.S. economy and brightened the outlook for riskier assets, according to big banks. The European Central Bank and the Bank of England sticking to their higher-for-longer rates stance, however, has blurred expectations for …

Factbox-What to expect in 2024: Fed pivot, cooling inflation, easing growth Read More »

BlackRock to invest up to $400 million in Dubai decarbonisation firm Positive Zero

By Yousef Saba DUBAI (Reuters) -BlackRock has agreed to invest up to $400 million in Dubai-based decarbonisation company Positive Zero through a diversified infrastructure fund, Positive Zero said in a statement on Monday. The investment will help Positive Zero, a decentralised decarbonisation infrastructure business, with its goal of boosting energy transition projects in Gulf countries, …

BlackRock to invest up to $400 million in Dubai decarbonisation firm Positive Zero Read More »

Unilever to sell Q-Tips maker Elida Beauty to Yellow Wood

(Reuters) -Consumer goods giant Unilever on Monday said it would sell Elida Beauty, its non-core beauty and personal care division, to U.S. private equity firm Yellow Wood Partners. The financial terms of the deal, expected to be completed in mid-2024, were not disclosed. Elida’s portfolio comprises of more than 20 beauty and personal care brands …

Unilever to sell Q-Tips maker Elida Beauty to Yellow Wood Read More »

Goldman cuts 2024 Brent price forecast on strong US supply

(Reuters) – Goldman Sachs trimmed its price expectation for Brent crude in 2024 by $10 per barrel to between $70 and $90, saying strong production from the United States would moderate any upside in oil prices. “We still look for range-bound prices and only moderate price volatility in 2024. Elevated spare capacity to handle tightening …

Goldman cuts 2024 Brent price forecast on strong US supply Read More »

Illumina to divest cancer test maker Grail after antitrust battles

(Reuters) -Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European antitrust enforcers for more than two years and faced fierce opposition from activist investor Carl Icahn. The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based …

Illumina to divest cancer test maker Grail after antitrust battles Read More »

Close Bitnami banner
Bitnami